1Shay DK, Holman RC, Roosevelt GE, et al. Bronchiolitis-associated mortality and estimates of respiratory syncytial virus-associated deaths among US children, 1979-1997. J Infect Dis, 2001, 183( 1 ):16-22.
2Feldman SA, Audet S, Beeler JA. The fusion glycoprotein of human respiratory syncytial virus facilitates virus attachment and infectivity via an interaction with cellular heparan sulfate. J Virol, 2000, 74( 14 ): 6442-6447.
3Maher CF, Hussell T, Blair E, et al. Recombinant respiratory syncytial virus lacking secreted glycoprotein G is attenuated, non- pathogenic but induces protective immunity. Microbes Infect, 2004,6(12): 1049- 1055.
4Becker Y. Respiratory syncytial virus (RSV) evades the human adaptive immune system by skewing the Th1/Th2 cytokine balance toward increased levels of Th2 cytokines and IgE, markers of allergy-a review. Virus Genes, 2006, 33(2): 235-252.
5Schwarze J, Schauer U. Enhanced virulence, airway inflammation and impaired lung function induced by respiratory syncytial virus deficient in secreted G protein. Thorax, 2004, 59(6): 517-521.
6Arnold R, Konig B, Werchau H, et al. Respiratory syncytlal virus deficient in soluble G protein induced an increased proinflammatory response in human lung epithelial cells. Virology, 2004, 330(2): 384-397.
7Varga SM, Wissinger EL, Braciale TJ. The attachment (G) glycoprotein of respiratory syncytial virus contains a single immunodominant epitope that elicits both Thl and Th2 CD4^+ T cell responses. J Immunol, 2000, 165( 11 ): 6487-6495.
8Huang Y, Anderson R. Modulation of protective immunity, eosinophilia, and cytokine responses by selective mutagenesis of a recombinant G protein vaccine against respiratory syncytial virus. J Virol, 2005,79 (7): 4527-4532.
9Patricia M. A. ea. HLA-DP4 presents an immunodominant peptide from the RSV G protein to CD4 T cells. J Virol Methods, 2004, 326(2): 220-230.
10Tripp RA, Jones LP, Haynes LM, et al. CX3C chemokine mimicry by respiratory syneytial virus G glyeoprotein. Nat Immunol, 2001, 2 (8): 732-738.
